학술논문
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective study
Document Type
Article
Author
Source
In: Journal of Gastrointestinal Oncology . (Journal of Gastrointestinal Oncology, December 2023, 14(6):2549-2558)
Subject
Language
English
ISSN
2219679X
20786891
20786891